awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35835795-3E34EE9C-E7E5-4051-84C2-69065CFE86B5
Q35835795-3E34EE9C-E7E5-4051-84C2-69065CFE86B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35835795-3E34EE9C-E7E5-4051-84C2-69065CFE86B5
Empowering targeted therapy: lessons from rituximab.
P2860
Q35835795-3E34EE9C-E7E5-4051-84C2-69065CFE86B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35835795-3E34EE9C-E7E5-4051-84C2-69065CFE86B5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f56ea340ec785a623d5d9eb17bf14a602eb98c9
P2860
Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance.